Abstract
Normal immune fonction is a critical factor in resistance to the opportunistic yeast Cryptococcus neoformans. Disseminated cryptococcosis is most commonly associated with underlying illness which predisposes to disease. Patients with neoplastic disease, particularly chronic lymphatic leukemia, Hodgkin’s disease, chronic myelogenous leukemia and multiple myeloma, are at particular risk. Other risk factors include collagen diseases, sarcoidiosis, and immunosuppression associated with organ transplantation. More recently, the Acquired Immunodeficiency Disease Syndrome (AIDS) has emerged as the most important predisposing condition for development of disseminated cryptococcosis. Patients with AIDS have a number of immunological defects; the specific deficiency that accounts for the high incidence of cryptococcosis in AIDS patient is not known. An area of current interest is the extent to which the yeast is able to modulate the host resistance. the effects of the yeast on host resistance may be a contributing factor to the progression of disease in immunocompromised individuals.
Keywords
- Host Resistance
- Cryptococcal Meningitis
- Capsular Polysaccharide
- Complement Cascade
- Alternative Complement Pathway
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Asherson GL, Colizzi V, Zembala M (1986) An overview of T-suppressor cell circuits. Ann Rev Immunol 4: 37–68
Baker PJ, Amsbaugh DF, Stashak PW, Caldes G, Prescott B (1982) Direct evidence for the involvement of T suppressor cells in the expression of low-dose paralysis to type III pneumococcal polysaccharide J Immunol 128: 1059–1062
Blackstock R, Hall NK, Hernandez NC (1989) Characterization of a suppressor factor that regulates phagocytosis by macrophages in murine cryptococcosis. Infect Immun 57: 1773–1779
Blackstock R, Hernandez NC (1988) Inhibition of macrophage phagocytosis in cryptococcosis: phenotypic analysis of the suppressor cell. Cell Immunol 114: 174–187
Blackstock R, Hernandez NC (1989) Characterization of the macrophage subset affected and its response to a T suppressor factor ( TsFmp) found in cryptococcosis. Infect Immun 57: 2931–2937
Blackstock R, McCormack JM, Hall NK (1987) Induction of a macrophage-suppressive lymphokine by soluble cryptococcal antigens and its association with models of immunologic tolerance. Infect Immun 55: 233–239
Breen JF, Lee IC, Vogel FR, Friedman H (1982) Cryptococcal capsular polysaccharide-induced modulation of murine immune responses. Infect Immun 36: 47–51
Cherniak R, Reiss E, Slodki ME, Plattner RD, Blumer SO (1980) Structure and antigenic activity of the capsular polysaccharide of Cryptococcus neoformans. Mol Immunol 17: 1025–1032
Cherniak R, Reiss E, Turner SH (1982) A galactoxylomannan antigen of Cryptococcus neoformans serotype A. Carbohydr Res 103: 239–250
Diamond RD, Bennett JE (1973) Disseminated cryptococcosis in man: decreased lymphocyte transformation in response to Cryptococcus neofonnans. J Infect Dis 127: 694–697
Diamond RD, Bennett JE (1974) Prognostic factors in cryptococcal meningitis: A study of 111 cases. Ann Intern Med 80: 176–181
Diamond RD, May JE, Kane M, Frank MM, Bennett JE (1973) The role of late complement components and the alternate complement pathway in experimental cryptococcosis. Proc Soc Exp Biol Med 144: 312–315
Diamond RD, May JE, Kane MA, Frank MM, Bennett JE (1974) The role of the classical and alternative complement pathways in host defenses against Cryptococcus neoformans infection. J Immunol 112:2260-.2270
Diamond RD, Erickson NF III (1982) Chemotaxis of human neutrophils and monocytes induced by Cryptococcus neoformans. Infect Immun 38: 380–382
Dorf ME, Benacerraf B (1984) Suppressor cells and immunoregulation. Ann Rev Immunol 2: 127–158
Dromer F, Perronne C, Barge J, Vilde JL, Yeni P (1989) Role of IgG and complement component C5 in the initial course of experimental cryptococcosis. Clin Exp Immunol 78: 412–417
Fidel PL Jr, Murphy JW (1988) Characterization of an in vitro-stimulated, Cryptococcus neoformans-specific second-order suppressor T cell and its precursor. Infect Immun 56: 1267–1272
Graybill JR, Alford RH (1974) Cell-mediated immunity in cryptococcosis. Cell Immunol 14: 12–21
Henderson DK, Bennett JE, Huber MA (1982) Long-lasting, specific immunologic unresponsiveness associated with cryptococcal meningitis. J Clin Invest 69: 1185–1190
Henderson DK, Kan VL, Bennett JE (1986) Tolerance to cryptococcal polysaccharide in cured cryptococcosis patients: failure of antibody secretion in vitro. Clin Exp Immunol 65: 639–646
Khakpour FR, Murphy JW (1987) Characterization of a third-order suppressor T cell (Ts3) induced by cryptococcal antigen(s). Infect Immun 55: 1657–1662
Kozel TR, Cazin J Jr (1974) Induction of humoral antibody response by soluble polysaccharide of Cryptococcus neoformans. Mycopathol Mycol App154: 21–30
Kozel TR, Gulley WF, Cazin J Jr (1977) Immune response to Cryptococcus neoformans soluble polysaccharide: immunological unresponsiveness. Infect Immun 18: 701–707
Kozel TR, Highison B, Stratton CH (1984) Localization on encapsulated Cryptococcus neoformans of serum components opsonic for phagocytosis by macrophages and neutrophils. Infect Immun 43: 574–579
Kozel TR, Pfrommer GST (1986) Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast. Infect Immun 52: 1–5
Kozel TR, Wilson MA, Pfrommer GST, Schlageter AM (1989) Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins. Infect Immun 57: 1922–1927
Laxalt KA, Kozel TR (1979) Chemotaxigenesis and activation of the alternative complement pathway by encapsulated and non-encapsulated Cryptococcus neofonnans. Infect Immun 26: 435–440
Lim TS, Murphy JW, Cauley LK (1980) Host-etiological agent interactions in intranasally and intraperitoneally induced cryptococcosis in mice. Infect Immun 29: 633–641
Macher AM, Bennett JE, Gadek JE, Frank MM (1978) Complement depletion in cryptococcal sepsis. J Immunol 120: 1686–1690
Morgan MA, Blackstock RA, Bulmer GS, Hall NK (1983) Modification of macrophage phagocytosis in murine cryptococcosis. Infect Immun 40: 493–500
Mosley RL, Murphy JW, Cox RA (1986) Immunoabsorption of Cryptococcus-specific suppressor T-cell factors. Infect Immun 51: 844–850
Murphy JW, Cox RA (1988) Induction of antigen-specific suppression by circulating Cryptococcus neofonnans antigen. Clin Exp Immunol 73: 174–180
Murphy JW, Cozad GC (1972) Immunological unresponsiveness induced by cryptococcal capsular polysaccharide assayed by the hemolytic plaque technique. Infect Immun 5: 896–901
Murphy JW, Moorhead JW (1982) Regulation of cell-mediated immunity in cryptococcosis. I. Induction of specific afferent T suppressor cells by cryptococcal antigen. J Immunol 128: 276–283
Murphy JW, Mosley RL (1985) Regulation of cell-mediated immunity in cryptococcosis. III. Characterization of second-order T-suppressor cells (Ts2). J Immunol 134: 577–584
Murphy JW, Mosley RL, Moorhead JW (1983) Regulation of cell-mediated immunity in cryptococosis. II. Characterization of first-order T-suppressor cells ( Tsl) and induction of second-order suppressor cells. J Immunol 130: 2876–2881
Murphy JW, Mosley RL, Cherniak R, Reyes GH, Kozel TR, Reiss E (1988) Serological, electrophoretic, and biological properties of Cryptococcus neofonmans antigens. Infect Immun 56: 424–431
Murphy JW (1989) Clearance of Cryptococcus neoformans from immunologically suppressed mice. Infect Immun 57: 1946–1952
Reiss E, Cherniak R, Eby R, Kaufman L (1984) Enzyme immunoassay detection of IgM to galactoxylomannan of Cryptococcus neofonnans. Diagn Immunol 2: 109–115
Rhodes JC (1985) Contribution of complement component C5 to the pathogenesis of experimental murine cryptococcosis. Sabouraudia 23: 225–234
Sanford JE, Lupan DM, Schlageter AM, Kozel TR (1990) Passive immunization against Cryptococcus neofonnans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect Immun 58: 1919–1923
Schimpff SC, Bennett JE (1975) Abnormalities in cell-mediated immunity in patients with Cryptococcus neofonmans infection. J Allergy Clin Immunol 55: 430–441
Turner SH, Cherniak R, Reiss E (1984) Fractionation and characterization of galactoxylomannan from Cryptococcus neofonnans. Carbohydr Res 125: 343–349
Vartivarian SE, Reyes GH, Jacobson ES, James PG, Cherniak R, Mumaw VR, Tingler MJ (1989) Localization of mannoprotein in Cryptococcus neofonnans. J Bacteriol 171: 6850–6852
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Kozel, T.R. (1991). Suppression of Host Resistance by Antigens of Cryptococcus Neoformans . In: Latgé, J.P., Boucias, D. (eds) Fungal Cell Wall and Immune Response. NATO ASI Series, vol 53. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76074-7_30
Download citation
DOI: https://doi.org/10.1007/978-3-642-76074-7_30
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76076-1
Online ISBN: 978-3-642-76074-7
eBook Packages: Springer Book Archive